203 related articles for article (PubMed ID: 35502801)
1. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
[TBL] [Abstract][Full Text] [Related]
2. Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.
Zhang JR; Johnson JC; Preble RG; Mujtaba M; Lea AS; Stevenson HL; Kueht M
Transpl Immunol; 2024 Jun; 84():102048. PubMed ID: 38641149
[TBL] [Abstract][Full Text] [Related]
3. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
Sandoval M; Nguyen DT; Huang HJ; Yi SG; Ghobrial RM; Gaber AO; Graviss EA
PLoS One; 2022; 17(12):e0279222. PubMed ID: 36542654
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
Aslam S; Adler E; Mekeel K; Little SJ
Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
[TBL] [Abstract][Full Text] [Related]
10. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
[TBL] [Abstract][Full Text] [Related]
11. Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.
Hamm SR; Rezahosseini O; Møller DL; Loft JA; Poulsen JR; Knudsen JD; Pedersen MS; Schønning K; Harboe ZB; Rasmussen A; Sørensen SS; Nielsen SD
Am J Transplant; 2022 Nov; 22(11):2637-2650. PubMed ID: 35801693
[TBL] [Abstract][Full Text] [Related]
12. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls.
Vinson AJ; Anzalone AJ; Sun J; Dai R; Agarwal G; Lee SB; French E; Olex A; Ison MG; Mannon RB;
Am J Transplant; 2022 Oct; 22(10):2418-2432. PubMed ID: 35674237
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
Mazuecos A; Villanego F; Zarraga S; López V; Oppenheimer F; Llinàs-Mallol L; Hernández AM; Rivas A; Ruiz-Fuentes MC; Toapanta NG; Jiménez C; Cabello S; Beneyto I; Aladrén MJ; Rodríguez-Benot A; Canal C; Molina M; Pérez-Flores I; Saura IM; Gavela E; Franco A; Lorenzo I; Galeano C; Tabernero G; Pérez-Tamajón L; Martín-Moreno PL; Fernández-Girón F; Siverio O; Labrador PJ; De Arriba G; Simal F; Cruzado L; Moina I; Alcalde G; Sánchez-Álvarez E; Pascual J; Crespo M;
Transplantation; 2022 Jul; 106(7):1430-1439. PubMed ID: 35384924
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
Bonazzetti C; Tazza B; Gibertoni D; Pasquini Z; Caroccia N; Fanì F; Fornaro G; Pascale R; Rinaldi M; Miani B; Gamberini C; Morelli MC; Tamé M; Busutti M; Comai G; Potena L; Borgese L; Salvaterra E; Lazzarotto T; Scudeller L; Viale P; Giannella M;
Clin Infect Dis; 2023 May; 76(10):1761-1767. PubMed ID: 36636955
[TBL] [Abstract][Full Text] [Related]
16. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.
Pereira MR; Arcasoy S; Farr MA; Mohan S; Emond JC; Tsapepas DS; Shi Q; Purpura L; Uhlemann AC; Zucker J; Verna EC
Transpl Infect Dis; 2021 Aug; 23(4):e13637. PubMed ID: 33993630
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Propensity-matched Analysis of a Large Research Network.
Hadi YB; Naqvi SFZ; Kupec JT; Sofka S; Sarwari A
Transplantation; 2021 Jun; 105(6):1365-1371. PubMed ID: 33988341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
